Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenza.
Pushko P, Tumpey TM, Van Hoeven N, Belser JA, Robinson R, Nathan M, Smith G, Wright DC, Bright RA.
Pushko P, et al. Among authors: robinson r.
Vaccine. 2007 May 22;25(21):4283-90. doi: 10.1016/j.vaccine.2007.02.059. Epub 2007 Mar 9.
Vaccine. 2007.
PMID: 17403562
We have previously shown that influenza virus-like particles (VLPs) comprised of HA, NA, and M1 proteins represent a candidate vaccine for avian influenza H9N2 virus [Pushko P, Tumpey TM, Fang Bu, Knell J, Robinson R, Smith G. Influenza virus-like particles comprise …
We have previously shown that influenza virus-like particles (VLPs) comprised of HA, NA, and M1 proteins represent a candidate vaccine for a …